Tag Archives: EGOV

Top Heal Care Stocks To Own For 2023

Shares of Johnson & Johnson JNJ, +0.92% inched 0.92% higher to $179.47 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX, -0.71% falling 0.71% to 4,448.08 and Dow Jones Industrial Average DJIA, -0.79% falling 0.79% to 35,343.28. This was the stock’s seventh consecutive day of gains. Johnson & Johnson hit a new 52-week high, surpassing its previous peak of $177.89, which the company achieved on August 16th.

The stock demonstrated....More>>>

Top 5 Performing Stocks For 2019

The dollar climbed against most of its rivals early Wednesday, but lost ground vs. the yen as geopolitical worries spurred buying in Japan’s haven currency.

Softer-than-expected economic reports from the eurozone and U.K. were helping to send traders toward the buck.

How are currencies performing?

The ICE U.S. Dollar Index
DXY, +0.28%
....More>>>

Top 5 Warren Buffett Stocks To Buy Right Now

Billionaire investor Warren Buffett said Monday he was close to making a big acquisition in the fourth quarter, but it fell apart.

“We had at least one deal possible that would have been very large,” Buffett told CNBC’s Becky Quick from Berkshire-owned Nebraska Furniture Mart on Monday. “I liked stocks in the fourth quarter, but I would like buying a business even better.”

Buffett added that he didn’t think the deal was on the table any longer but did not say why not. When pressed for further details on the mystery deal, Buffett said, “I’ll....More>>>

Top 10 High Tech Stocks To Watch Right Now

What happened

After the Food and Drug Administration greenlit the use of software that can suspend insulin when its insulin pump is used in conjunction with DexCom’s (NASDAQ:DXCM) continuous glucose monitor (CGM), shares of Tandem Diabetes Care (NASDAQ:TNDM) are rallying 10.2% at 12:45 p.m. EDT on Friday.

So what

Historically, diabetes patients can spend up to 70% of their day outside their desired blood glucose range, and as a result, they’re at risk of seeing their disease progress to a point where it causes life-threatening complications.

IMAGE....More>>>

Top 10 Medical Stocks To Buy For 2019

InVitae (NYSE: NVTA) and Natera (NASDAQ:NTRA) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, analyst recommendations, institutional ownership, valuation, risk and earnings.

Risk and Volatility

Get InVitae alerts:

InVitae has a beta of 1.2, indicating that its stock price is 20% more volatile than the S&P 500. Comparatively, Natera has a beta of 2.07, indicating that its stock price is 107% more volatile than the S&P 500.

....More>>>